{ "company_number": "06970743", "name": "Cell Therapy Limited", "url": "/company/06970743", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2009-07-23", "dissolved_on": null, "sic_codes": [ { "code": "72190", "description": "Other research and experimental development on natural sciences and engineering", "section": "M", "section_name": "Professional, scientific and technical activities", "url": "/sic/72190" } ], "registered_address": { "id": 2744439, "url": "/address/2744439", "line1": "CELIXIR HOUSE STRATFORD-UPON-AVON BUSINESS AND TECHNOLOGY PARK", "line2": "INNOVATION WAY", "post_town": "STRATFORD-UPON-AVON", "county": "", "country": "ENGLAND", "postcode": "CV37 7GZ" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06970743", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-12-31", "last_made_up": "2025-03-31", "category": "SMALL", "filings": [ { "url": "/company/06970743/accounts/2025-03-31", "pdf_url": "/company/06970743/accounts/2025-03-31.pdf", "made_up_date": "2025-03-31", "period_start": "2025-03-31", "period_end": "2025-03-31", "entity_name": "Cell Therapy Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "613154.00", "debtors": "446650.00", "cash_bank_in_hand": "29530.00", "current_assets": "476180.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-4324310.00", "total_assets_less_current_liabilities": "-3711156.00", "net_assets_liabilities": "-3779356.00", "called_up_share_capital": "19964.00", "profit_loss_account_reserve": "-14254188.00", "shareholder_funds": "19964.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2025.zip" }, { "url": "/company/06970743/accounts/2024-03-31", "pdf_url": "/company/06970743/accounts/2024-03-31.pdf", "made_up_date": "2024-03-31", "period_start": "2024-03-31", "period_end": "2024-03-31", "entity_name": "Cell Therapy Limited", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "678922.00", "debtors": "454355.00", "cash_bank_in_hand": "153090.00", "current_assets": "607445.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-4236499.00", "total_assets_less_current_liabilities": "-3557577.00", "net_assets_liabilities": "-10682911.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "19964.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2024.zip" }, { "url": "/company/06970743/accounts/2023-03-31", "pdf_url": "/company/06970743/accounts/2023-03-31.pdf", "made_up_date": "2023-03-31", "period_start": "2023-03-31", "period_end": "2023-03-31", "entity_name": "Cell Therapy Limited", "dormant": false, "average_employees": "6.00", "tangible_fixed_assets": "761929.00", "debtors": "1258180.00", "cash_bank_in_hand": "285158.00", "current_assets": "1543338.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-3035188.00", "total_assets_less_current_liabilities": "-2273259.00", "net_assets_liabilities": "-10178342.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "19964.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2023.zip" }, { "url": "/company/06970743/accounts/2022-03-31", "pdf_url": "/company/06970743/accounts/2022-03-31.pdf", "made_up_date": "2022-03-31", "period_start": "2022-03-31", "period_end": "2022-03-31", "entity_name": "Cell Therapy Limited", "dormant": false, "average_employees": "11.00", "tangible_fixed_assets": "747034.00", "debtors": "1321901.00", "cash_bank_in_hand": "263058.00", "current_assets": "1584959.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-2505710.00", "total_assets_less_current_liabilities": "-1758676.00", "net_assets_liabilities": "-10092009.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "19964.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2022.zip" }, { "url": "/company/06970743/accounts/2013-07-31", "pdf_url": "/company/06970743/accounts/2013-07-31.pdf", "made_up_date": "2013-07-31", "period_start": "2013-07-31", "period_end": "2013-07-31", "entity_name": "Cell Therapy Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "71324.00", "debtors": "152929.00", "cash_bank_in_hand": "32228.00", "current_assets": "192443.00", "creditors_due_within_one_year": "15589.00", "creditors_due_after_one_year": "624203.00", "net_current_assets_liabilities": "176854.00", "total_assets_less_current_liabilities": "248178.00", "net_assets_liabilities": "-376025.00", "called_up_share_capital": "235710.00", "profit_loss_account_reserve": "-611735.00", "shareholder_funds": "-376025.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2014.zip" }, { "url": "/company/06970743/accounts/2012-07-31", "pdf_url": "/company/06970743/accounts/2012-07-31.pdf", "made_up_date": "2012-07-31", "period_start": "2012-07-31", "period_end": "2012-07-31", "entity_name": "Cell Therapy Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "47835.00", "debtors": null, "cash_bank_in_hand": "168987.00", "current_assets": "168987.00", "creditors_due_within_one_year": "87018.00", "creditors_due_after_one_year": "211080.00", "net_current_assets_liabilities": "81969.00", "total_assets_less_current_liabilities": "129804.00", "net_assets_liabilities": "-81276.00", "called_up_share_capital": "225390.00", "profit_loss_account_reserve": "-306666.00", "shareholder_funds": "-81276.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2013.zip" }, { "url": "/company/06970743/accounts/2011-07-31", "pdf_url": "/company/06970743/accounts/2011-07-31.pdf", "made_up_date": "2011-07-31", "period_start": "2011-07-31", "period_end": "2011-07-31", "entity_name": "Cell Therapy Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "36396.00", "debtors": "5783.00", "cash_bank_in_hand": null, "current_assets": "163264.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "117973.00", "total_assets_less_current_liabilities": "154369.00", "net_assets_liabilities": "-15673.00", "called_up_share_capital": "100000.00", "profit_loss_account_reserve": "-115673.00", "shareholder_funds": "-15673.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2012.zip" }, { "url": "/company/06970743/accounts/2010-07-31", "pdf_url": "/company/06970743/accounts/2010-07-31.pdf", "made_up_date": "2010-07-31", "period_start": "2010-07-31", "period_end": "2010-07-31", "entity_name": "Cell Therapy Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "10000.00", "debtors": "5224.00", "cash_bank_in_hand": "74974.00", "current_assets": "80198.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "65898.00", "total_assets_less_current_liabilities": "75898.00", "net_assets_liabilities": "-10170.00", "called_up_share_capital": "10000.00", "profit_loss_account_reserve": "-20170.00", "shareholder_funds": "-10170.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2011.zip" } ], "pdf_only_filings": [ { "made_up_date": "2021-03-31", "filing_date": "2021-08-31", "form_type": "AA", "description": "accounts-with-accounts-type-small", "paper_filed": true, "pdf_url": "/company/06970743/accounts/2021-03-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06970743/filing-history/MzMxMTI5Mzk3NWFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2020-07-31", "filing_date": "2021-02-23", "form_type": "AA", "description": "accounts-with-accounts-type-full", "paper_filed": true, "pdf_url": "/company/06970743/accounts/2020-07-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06970743/filing-history/MzI5MjEyNTA5MWFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2019-07-31", "filing_date": "2020-02-05", "form_type": "AA", "description": "accounts-with-accounts-type-full", "paper_filed": true, "pdf_url": "/company/06970743/accounts/2019-07-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06970743/filing-history/MzI1NjI5MzM0MGFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2018-07-31", "filing_date": "2019-05-08", "form_type": "AA", "description": "accounts-with-accounts-type-full", "paper_filed": true, "pdf_url": "/company/06970743/accounts/2018-07-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06970743/filing-history/MzIzMzUzMTQ4M2FkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2017-07-31", "filing_date": "2018-05-04", "form_type": "AA", "description": "accounts-with-accounts-type-full", "paper_filed": true, "pdf_url": "/company/06970743/accounts/2017-07-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06970743/filing-history/MzIwNDE3MTEyMmFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2016-07-31", "filing_date": "2017-05-04", "form_type": "AA", "description": "accounts-with-accounts-type-group", "paper_filed": true, "pdf_url": "/company/06970743/accounts/2016-07-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06970743/filing-history/MzE3NTAzODE0MmFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2015-07-31", "filing_date": "2015-11-24", "form_type": "AA", "description": "accounts-with-accounts-type-full", "paper_filed": true, "pdf_url": "/company/06970743/accounts/2015-07-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06970743/filing-history/MzEzNTUzNjUzNGFkaXF6a2N4/document?format=pdf&download=0" }, { "made_up_date": "2014-07-31", "filing_date": "2015-05-11", "form_type": "AA", "description": "accounts-with-accounts-type-full", "paper_filed": null, "pdf_url": "/company/06970743/accounts/2014-07-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06970743/filing-history/MzEyMjUyMjI4NWFkaXF6a2N4/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/06970743/filing-history" }, "confirmation_statement": { "next_due": "2027-03-13", "last_made_up": "2026-02-27" }, "officers": [], "psc": [ { "name": "Trevor Ajan Reginald", "kind": "individual-person-with-significant-control", "person_url": "/person/5084333", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": "2017-04-12", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Dr Mubasher Shiekh", "kind": "individual-person-with-significant-control", "person_url": "/person/3495311", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": "2017-04-12", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Sir Martin John Evans", "kind": "individual-person-with-significant-control", "person_url": "/person/3178535", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": "2017-04-12", "nationality": "British", "country_of_residence": "Wales", "source": "snapshot" }, { "name": "Celixir Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/10541091", "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2017-04-12", "ceased_on": "2025-01-06", "nationality": "", "country_of_residence": "", "source": "snapshot" }, { "name": "Cardiogeni Plc", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/10541091", "natures_of_control": [ "significant-influence-or-control", "significant-influence-or-control-as-firm" ], "notified_on": "2025-01-06", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-20T03:23:56.377763+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }